Paul Berg is a statistician at Eli Lilly & Company, where they serve as Sr Director of ExploR&D Statistics, focusing on customized R&D solutions for biotech companies. With extensive experience in clinical trials, their past roles include Research Scientist and Principal Research Scientist at Eli Lilly, where they specialized in schizophrenia, bipolar disorder, and other therapeutic areas. Additionally, Paul is an adjunct lecturer at the Indiana University School of Medicine, sharing their expertise in biostatistics and epidemiology. Paul holds an M.S. in Biostatistics and Epidemiology from the Medical University of South Carolina and a B.S. in Mathematics from the University of Notre Dame.
This person is not in the org chart
This person is not in any teams
This person is not in any offices